Veru's VERU-111 Moves Into Pivotal COVID-19 Study Home > Business > Article
3 years ago By Austine — Veru Inc (NASDAQ: VERU) will start testing VERU-111 in the registrational Phase 3 study in hospitalized patients who have COVID-19 virus infection and are
#veru #intopivotal